东瑞制药:胡硕获委任为非执行董事
Core Viewpoint - Dongrui Pharmaceutical (02348) announced the appointment of Mr. Hu Shuo as a non-executive director, effective from August 1, 2025 [1] Company Summary - The appointment of Mr. Hu Shuo is a strategic move for Dongrui Pharmaceutical, indicating potential changes in governance and direction [1]